Literature DB >> 3507686

The crystal structure of alpha-bungarotoxin at 2.5 A resolution: relation to solution structure and binding to acetylcholine receptor.

R A Love1, R M Stroud.   

Abstract

We report collection of 2.5 A resolution X-ray diffraction data from newly grown crystals of the rare 'small unit cell' form of the long snake neurotoxin, alpha-bungarotoxin. The previous model of the molecule has been rebuilt, and refined using least-square methods to a crystallographic residual of 0.24 at 2.5 A resolution. alpha-Bungarotoxin's crystal structure is compared with the crystal structures of two other snake neurotoxins (cobratoxin and erabutoxin), and with its solution structure inferred from spectroscopic studies. Significant differences include less beta-sheet in bungarotoxin's crystal structure than in solution, or in the crystal structures of other neurotoxins, and an unusual orientation in the crystal of the invariant tryptophan. The functional, binding surface of bungarotoxin is described; it consists primarily of hydrophobic and hydrogen-bonding groups and only a few charged side-chains. The structure is compared with experimental binding parameters for neurotoxins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3507686     DOI: 10.1093/protein/1.1.37

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  25 in total

1.  Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.

Authors:  Martha Marinou; Socrates J Tzartos
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

2.  Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin.

Authors:  Luisa Bracci; Alessandro Pini; Andrea Bernini; Barbara Lelli; Claudia Ricci; Maria Scarselli; Neri Niccolai; Paolo Neri
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

3.  Alpha-bungarotoxin binding to acetylcholine receptor membranes studied by low angle X-ray diffraction.

Authors:  Howard S Young; Leo G Herbette; Victor Skita
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

4.  Solution conformation of alpha-conotoxin GIC, a novel potent antagonist of alpha3beta2 nicotinic acetylcholine receptors.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Baldomero M Olivera; J Michael McIntosh; Kyou-Hoon Han
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

5.  Acetylcholine receptor-alpha-bungarotoxin interactions: determination of the region-to-region contacts by peptide-peptide interactions and molecular modeling of the receptor cavity.

Authors:  K H Ruan; J Spurlino; F A Quiocho; M Z Atassi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Statistical analysis of interface similarity in crystals of homologous proteins.

Authors:  Qifang Xu; Adrian A Canutescu; Guoli Wang; Maxim Shapovalov; Zoran Obradovic; Roland L Dunbrack
Journal:  J Mol Biol       Date:  2008-06-07       Impact factor: 5.469

7.  Three-dimensional solution structure of the complex of alpha-bungarotoxin with a library-derived peptide.

Authors:  T Scherf; M Balass; S Fuchs; E Katchalski-Katzir; J Anglister
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

8.  State of functionally essential Trp-29 in snake venom neurotoxins: a proton nuclear magnetic resonance study.

Authors:  T Endo; M Oya; F J Joubert; K Hayashi; T Miyazawa
Journal:  J Protein Chem       Date:  1989-08

Review 9.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

10.  Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera.

Authors:  Sun Huang; Shu-Xing Li; Nina Bren; Kevin Cheng; Ryan Gomoto; Lin Chen; Steven M Sine
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.